29.04.2024 15:04:23 - dpa-AFX: *FDA OKS ABBOTT'S ESPRIT BTK EVEROLIMUS ELUTING RESORBABLE SCAFFOLD SYSTEM FOR CHRONIC LIMB-THREATENING ISCHEMIA

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Abbott Laboratories 850103 NYSE 103,220 15.07.24 20:39:37 -1,000 -0,96% 103,210 103,230 103,930 104,220

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH